Sentence examples for technology assessment process from inspiring English sources
Yet, MNP adoption is limited by a multi-component technology assessment process focused primarily on the technology's applicability to project-based outcomes.
Based on this examination, technology options which are suitable for the area can be identified A set of household questionnaire 4 Contextualization of technology assessment process (CTX step) A set of technology assessment indicators is designed to evaluate technology options (these technology options have been identified from step 2 and 3).
The published checklist will be used officially by the HTA Office in the pharmaceutical's single health technology assessment process.
The use of cost-effectiveness analysis has become an important part of the health technology assessment process [ 1].
Regarding the technology assessment process, the broad range of observed anomalies can be interpreted as symptoms, which may be indicative of specific underlying problems.
Our study aimed to develop a scientifically rigorous and detailed appraisal checklist for economic evaluations of pharmaceuticals in the single health technology assessment process.
It ends by exploring wider implications and challenges for national and international technology assessment processes that focus on global sustainable development challenges.
The Capability Assessment and Tradeoff Environment (CATE) has been created to support aerospace vehicle decision making with structured vehicle and technology assessment processes and tools.
Public and patient involvement in the different stages of the health technology assessment (HTA) process is increasingly encouraged.
To compare the timelines and recommendations of the Scottish Medicines Consortium (SMC) and National Institute of Health and Clinical Excellence (NICE), in particular since the single technology assessment (STA) process was introduced in 2005.
This is because high price itself might not directly translate into high revenue: sales volume might be reduced drastically if an expensive pharmaceutical product falls under scrutiny of health care payers and is refused reimbursement or is not recommended for use by health technology assessment (HTA) process.
